Vytorin Falls Short of New Indication for CKD Patients - Family Practice News Digital Network PDF Print

Vytorin Falls Short of New Indication for CKD Patients
Family Practice News Digital Network
This was despite the unanimous recommendation of the FDA's Endocrinologic and Metabolic Drugs Advisory Committee in November to approve Vytorin for reducing major cardiovascular events in patients with CKD who are not on dialysis.
FDA Rejects Proposed Chronic Kidney Disease Indication for Vytorin Forbes

all 4 news articles »

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.